Sigyn Therapeutics, Inc.
SIGY
$2.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.14% | -117.05% | -27.89% | 56.32% | -38.79% |
| Total Depreciation and Amortization | -- | -100.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | 54.22% | 0.90% | 12.95% | -70.20% | 40.08% |
| Total Other Non-Cash Items | -94.49% | 1,715.20% | 290.84% | -108.96% | 680.00% |
| Change in Net Operating Assets | -48.06% | 33.53% | 34.34% | -60.31% | -1.39% |
| Cash from Operations | -30.77% | 48.23% | -1.45% | -77.17% | 10.39% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 103.14% | -52.57% | 63.09% | -39.97% | 31.89% |
| Total Debt Repaid | -- | -- | -- | -63.16% | -6.40% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103.14% | -52.57% | 114.53% | -49.96% | 35.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 786.29% | -1,650.00% | 100.52% | -237.35% | 434.13% |